Distinguishing Pancreatic Cancer From Autoimmune Pancreatitis: A Comparison of Two Strategies

Aravind Sugumar, Suresh T Chari

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Autoimmune pancreatitis is a rare disease which closely mimics pancreatic cancer in its presentation. It is important for clinicians to distinguish one from the other due to vastly different therapeutic and prognostic implications. We compared 2 recently proposed strategies, 1 from Japan and the other from the United States, to distinguish autoimmune pancreatitis from pancreatic cancer. While both strategies have inherent strengths and weaknesses, we believe that the best features of both need prospective validation. The strategy proposed from Japan is simple to use, but is based on a small number of patients and is heavily dependent on imaging criteria. The American strategy while based on a bigger sample of patients is complicated and is most useful in expert hands. Additionally, differences in clinical practice and local preference in the use of certain diagnostic tests need to be considered while adopting either strategy.

Original languageEnglish (US)
JournalClinical Gastroenterology and Hepatology
Volume7
Issue number11 SUPPL.
DOIs
StatePublished - Nov 2009

Fingerprint

Pancreatic Neoplasms
Pancreatitis
Japan
Rare Diseases
Routine Diagnostic Tests
Hand
Therapeutics

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Distinguishing Pancreatic Cancer From Autoimmune Pancreatitis : A Comparison of Two Strategies. / Sugumar, Aravind; Chari, Suresh T.

In: Clinical Gastroenterology and Hepatology, Vol. 7, No. 11 SUPPL., 11.2009.

Research output: Contribution to journalArticle

@article{06118cada35343719e3ac008816a0ef7,
title = "Distinguishing Pancreatic Cancer From Autoimmune Pancreatitis: A Comparison of Two Strategies",
abstract = "Autoimmune pancreatitis is a rare disease which closely mimics pancreatic cancer in its presentation. It is important for clinicians to distinguish one from the other due to vastly different therapeutic and prognostic implications. We compared 2 recently proposed strategies, 1 from Japan and the other from the United States, to distinguish autoimmune pancreatitis from pancreatic cancer. While both strategies have inherent strengths and weaknesses, we believe that the best features of both need prospective validation. The strategy proposed from Japan is simple to use, but is based on a small number of patients and is heavily dependent on imaging criteria. The American strategy while based on a bigger sample of patients is complicated and is most useful in expert hands. Additionally, differences in clinical practice and local preference in the use of certain diagnostic tests need to be considered while adopting either strategy.",
author = "Aravind Sugumar and Chari, {Suresh T}",
year = "2009",
month = "11",
doi = "10.1016/j.cgh.2009.07.034",
language = "English (US)",
volume = "7",
journal = "Clinical Gastroenterology and Hepatology",
issn = "1542-3565",
publisher = "W.B. Saunders Ltd",
number = "11 SUPPL.",

}

TY - JOUR

T1 - Distinguishing Pancreatic Cancer From Autoimmune Pancreatitis

T2 - A Comparison of Two Strategies

AU - Sugumar, Aravind

AU - Chari, Suresh T

PY - 2009/11

Y1 - 2009/11

N2 - Autoimmune pancreatitis is a rare disease which closely mimics pancreatic cancer in its presentation. It is important for clinicians to distinguish one from the other due to vastly different therapeutic and prognostic implications. We compared 2 recently proposed strategies, 1 from Japan and the other from the United States, to distinguish autoimmune pancreatitis from pancreatic cancer. While both strategies have inherent strengths and weaknesses, we believe that the best features of both need prospective validation. The strategy proposed from Japan is simple to use, but is based on a small number of patients and is heavily dependent on imaging criteria. The American strategy while based on a bigger sample of patients is complicated and is most useful in expert hands. Additionally, differences in clinical practice and local preference in the use of certain diagnostic tests need to be considered while adopting either strategy.

AB - Autoimmune pancreatitis is a rare disease which closely mimics pancreatic cancer in its presentation. It is important for clinicians to distinguish one from the other due to vastly different therapeutic and prognostic implications. We compared 2 recently proposed strategies, 1 from Japan and the other from the United States, to distinguish autoimmune pancreatitis from pancreatic cancer. While both strategies have inherent strengths and weaknesses, we believe that the best features of both need prospective validation. The strategy proposed from Japan is simple to use, but is based on a small number of patients and is heavily dependent on imaging criteria. The American strategy while based on a bigger sample of patients is complicated and is most useful in expert hands. Additionally, differences in clinical practice and local preference in the use of certain diagnostic tests need to be considered while adopting either strategy.

UR - http://www.scopus.com/inward/record.url?scp=71849103709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71849103709&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2009.07.034

DO - 10.1016/j.cgh.2009.07.034

M3 - Article

C2 - 19896101

AN - SCOPUS:71849103709

VL - 7

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

IS - 11 SUPPL.

ER -